Damian Rieke, physician associate at the Charité Comprehensive Cancer Center, received the Merit Award at the ASCO Anual Meeting 2023, held June 02-06 in Chicago. We sincerely congratulate him and the team on this achievement.
The congress of the American Society of Clinical Oncology (ASCO) presents the latest findings in the field of cancer research.
The topic: “Tumor mutational burden as a predictive biomarker for molecularly matched therapy in two independent pan-cancer cohorts.” received the award. In the abstract, the team of the molecular tumor conference and collaborators from the DKTK and WIN Consortium identified tumor mutational burden as a negative predictive biomarker for personalized therapies.
These findings might help to better stratify patients in molecular tumor boards.
Click here for meeting abstract.
Back to Overview